Pennant Investors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-32,400
Closed -$133K 43
2024
Q2
$133K Hold
32,400
0.03% 42
2024
Q1
$511K Hold
32,400
0.13% 21
2023
Q4
$491K Buy
+32,400
New +$491K 0.11% 20